Package 67877-223-05

{"route": ["ORAL"], "spl_id": "4a89b23c-8061-4a4f-827e-62ec74d59be5", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310430", "310431", "310432"], "spl_set_id": ["722de2a9-38b3-4518-b262-ba0d1346d0ba"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (67877-223-01)", "package_ndc": "67877-223-01", "marketing_start_date": "20110129"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (67877-223-05)", "package_ndc": "67877-223-05", "marketing_start_date": "20110129"}, {"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (67877-223-10)", "package_ndc": "67877-223-10", "marketing_start_date": "20110129"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (67877-223-38)  / 10 CAPSULE in 1 BLISTER PACK", "package_ndc": "67877-223-38", "marketing_start_date": "20200327"}], "brand_name": "Gabapentin", "product_id": "67877-223_4a89b23c-8061-4a4f-827e-62ec74d59be5", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "67877-223", "generic_name": "Gabapentin", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "300 mg/1"}], "application_number": "ANDA090858", "marketing_category": "ANDA", "marketing_start_date": "20110129", "listing_expiration_date": "20261231"}